219 related articles for article (PubMed ID: 17952373)
1. Management of ocular complications of Vogt-Koyanagi-Harada syndrome.
Perente I; Utine CA; Cakir H; Kaya V; Tutkun IT; Yilmaz OF
Int Ophthalmol; 2009 Feb; 29(1):33-7. PubMed ID: 17952373
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
3. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
5. Echographic features of the Vogt-Koyanagi-Harada syndrome.
Forster DJ; Cano MR; Green RL; Rao NA
Arch Ophthalmol; 1990 Oct; 108(10):1421-6. PubMed ID: 2222275
[TBL] [Abstract][Full Text] [Related]
6. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
Agarwal A; Freund KB; Kumar A; Aggarwal K; Sharma D; Katoch D; Bansal R; Gupta V;
Retina; 2021 Apr; 41(4):774-783. PubMed ID: 32833410
[TBL] [Abstract][Full Text] [Related]
7. Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis.
Latronico ME; Rigante D; Caso F; Cantarini L; Costa L; Nieves-Martín L; Traversi C; Franceschini R
Clin Rheumatol; 2015 Jun; 34(6):1145-8. PubMed ID: 24763751
[TBL] [Abstract][Full Text] [Related]
8. Point-of-Care Ultrasound Diagnosis of Bilateral Retinal Detachment Associated With Vogt-Koyanagi-Harada Disease in the Pediatric Emergency Department.
Yeh JP; Kwan CW; Weerdenburg K; Fischer JW
Pediatr Emerg Care; 2016 Sep; 32(9):639-41. PubMed ID: 26890299
[TBL] [Abstract][Full Text] [Related]
9. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
[TBL] [Abstract][Full Text] [Related]
10. Vogt-Koyanagi-Harada disease.
Damico FM; Kiss S; Young LH
Semin Ophthalmol; 2005; 20(3):183-90. PubMed ID: 16282153
[TBL] [Abstract][Full Text] [Related]
11. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravitreal dexamethasone implant in patients with Vogt-Koyanagi-Harada Disease and bilateral panuveitis: Two case reports.
Chen PL; Chen SN
Medicine (Baltimore); 2021 Oct; 100(40):e27394. PubMed ID: 34622843
[TBL] [Abstract][Full Text] [Related]
13. SUB-TENON TRIAMCINOLONE ACETONIDE INJECTION IN A PREGNANT PATIENT WITH VOGT-KOYANAGI-HARADA DISEASE.
Nakamura T; Keino H; Okada AA
Retin Cases Brief Rep; 2018 Fall; 12(4):375-378. PubMed ID: 28033228
[TBL] [Abstract][Full Text] [Related]
14. Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
Li AS; Tang PH; Do DV
JAMA Ophthalmol; 2020 May; 138(5):e191981. PubMed ID: 32407448
[No Abstract] [Full Text] [Related]
15. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
[TBL] [Abstract][Full Text] [Related]
16. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease.
Khalifa Y; Loh AR; Acharya NR
Ocul Immunol Inflamm; 2009; 17(6):431-3. PubMed ID: 20001265
[TBL] [Abstract][Full Text] [Related]
17. Suprachoroidal triamcinolone acetonide injection: a novel therapy for serous retinal detachment due to Vogt-Koyanagi Harada disease.
Tabl AA; Elsayed MA; Tabl MA
Eur J Ophthalmol; 2022 Nov; 32(6):3482-3488. PubMed ID: 35266801
[TBL] [Abstract][Full Text] [Related]
18. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy.
Takayama K; Obata H; Takeuchi M
Ocul Immunol Inflamm; 2020 Apr; 28(3):509-512. PubMed ID: 31268769
[No Abstract] [Full Text] [Related]
20. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
Hedayatfar A; Hosseini SM; Karimi N; Falavarjani KG; Badie N; Zameni M; Soheilian M
Int Ophthalmol; 2018 Apr; 38(2):443-449. PubMed ID: 28260142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
